Friday, January 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Featured News

NIAID Seeks Support Services for Infectious Diseases Research

by Global Biodefense Staff
September 26, 2017
NIAID Researcher Conducts Infectious Disease Research Under the Hood

NIAID researcher conducts laboratory studies under the biosafety hood. Image: NIH/NIAID

The National Institute of Allergy and Infectious Diseases (NIAID) is competing a support contract for scientific, professional and technical expertise for NIAID’s research programs.

NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. Infectious diseases include global killers such as Ebola, Zika, human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), tuberculosis (TB), and malaria; emerging or reemerging threats such as influenza, multiple drug resistant tuberculosis (MDR TB), and methicillin resistant Staphylococcus aures (MRSA); and potential agents of bioterrorism.

New and expanding Congressional mandates, rapid evolution of research tools and technical capabilities, changing policies and information technologies, expanding research programs, and NIAID’s leadership role in the global community has resulted in a critical requirement to obtain highly specialized scientific and technical services of a contractor capable of flexible assignments and availability.

It is anticipated that one indefinite delivery/indefinite quantity type contract will be awarded for a five-year period beginning on or about March 1, 2018. The Contractor shall be reimbursed by the Government in an amount not less than a total of $10,000 (minimum) nor more than a total of $112,000,000 (maximum) for successful performance of the proposed contract.

Further details are available via Solicitation Number: NIAID-OD-NIHAO2017057.

Tags: EbolaHIVMRSANIAIDRequest for ProposalsTuberculosisZika

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC